PMC:7417114 / 56492-56756 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/7417114","sourcedb":"PMC","sourceid":"7417114","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7417114","text":"Alvocidib\n(Tolero Pharmaceuticals) Dose (infusion dose plus loading dose), mg, 30+30, AUC (0-infinity) 14.5 uM*h/mL; Vz value = 367 L No information available \u003e95% binding (HSA) Alvocidib-related pro-inflammatory syndrome is associated with induction of IL-6 (237)","divisions":[{"label":"td","span":{"begin":0,"end":34}},{"label":"p","span":{"begin":0,"end":9}},{"label":"p","span":{"begin":10,"end":34}},{"label":"td","span":{"begin":35,"end":133}},{"label":"td","span":{"begin":134,"end":158}},{"label":"td","span":{"begin":159,"end":177}}],"tracks":[{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T277","span":{"begin":254,"end":256},"obj":"Body_part"}],"attributes":[{"id":"A277","pred":"fma_id","subj":"T277","obj":"http://purl.org/sig/ont/fma/fma86578"},{"subj":"T277","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T535","span":{"begin":173,"end":176},"obj":"Disease"}],"attributes":[{"id":"A535","pred":"mondo_id","subj":"T535","obj":"http://purl.obolibrary.org/obo/MONDO_0011848"},{"subj":"T535","pred":"source","obj":"LitCovid-PD-MONDO"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T634","span":{"begin":173,"end":176},"obj":"http://purl.obolibrary.org/obo/PR_000001932"}],"attributes":[{"subj":"T634","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T53","span":{"begin":254,"end":256},"obj":"Chemical"}],"attributes":[{"id":"A12614","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A46200","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"subj":"T53","pred":"source","obj":"LitCovid-PD-CHEBI"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T470","span":{"begin":0,"end":9},"obj":"Sentence"},{"id":"T471","span":{"begin":10,"end":264},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T470","pred":"source","obj":"LitCovid-sentences"},{"subj":"T471","pred":"source","obj":"LitCovid-sentences"}]},{"project":"2_test","denotations":[{"id":"32778962-12576419-84130750","span":{"begin":260,"end":263},"obj":"12576419"}],"attributes":[{"subj":"32778962-12576419-84130750","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-FMA-UBERON","color":"#93ece5","default":true},{"id":"LitCovid-PD-MONDO","color":"#eccb93"},{"id":"LitCovid-PD-CLO","color":"#b193ec"},{"id":"LitCovid-PD-CHEBI","color":"#93ec97"},{"id":"LitCovid-sentences","color":"#ec93a8"},{"id":"2_test","color":"#93c3ec"}]}]}}